Catalio Capital Management, LP
NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$538.3M2026 Q3
Positions47
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.48.4%
What Changed This Quarter?
Top Holdings
AVLN
Avalyn Pharma
9.0%
BMY
Bristol Myers Squibb
5.8%
BBIO
BridgeBio Pharma
5.2%
PBLS
Parabilis Medicines
4.9%
JNJ
Johnson & Johnson
4.9%
ASND
Ascendis Pharma A/S
4.3%
ARWR
Arrowhead Pharmaceuticals
3.8%
SNDX
Syndax Pharmaceuticals
3.6%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.